Departement
Klinische Forschung
Achtung: Diese Seite kann nur von Administratoren besucht werden, da Sie nicht freigeschalten wurde.
Zurück
Publications Meier Christian

Effect of a physical activity intervention on lower body bone health in childhood cancer survivors: A randomized controlled trial (SURfit).

Jung R; Zürcher SJ; Schindera C; Eser P; Meier C; Schai A; Braun J; Deng WH; Hebestreit H; Neuhaus C; Schaeff J; Rueegg CS; von der Weid NX; Kriemler S. International Journal of Cancer. 2023.

Adherence to bone health guidelines in patients with hormone receptor-positive early breast cancer: Status and clinical impact in a Swiss cohort experience.

Bischof E; Schwab FD; Georgescu Margarint EL; Montavon C; Zünti I; Schollbach A; Schötzau A; Hirschmann A; Landin J; Meier C; Christian K; Vetter M. Bone Reports. 2022.

Association between glycemic control and risk of venous thromboembolism in diabetic patients: a nested case-control study.

R Charlier SH; Meier C; Jick SS; Meier CR; Becker C. Cardiovascular Diabetology. 2022.

Bariatric surgery and skeletal health: A narrative review and position statement for management by the European Calcified Tissue Society (ECTS)

Paccou J.; Tsourdi E.; Meier C.; Palermo A.; Pepe J.; Body J.-J.; Zillikens M.C.. Bone. 2022.

Bone Microarchitecture and Strength in Long-Standing Type 1 Diabetes.

Sewing L; Potasso L; Baumann S; Schenk D; Gazozcu F; Lippuner K; Kraenzlin M; Zysset P; Meier C. Journal of Bone and Mineral Research. 2022.

Determinants of Low Bone Turnover in Type 2 Diabetes-the Role of PTH.

Vavanikunnel J; Sewing L; Triantafyllidou M; Steighardt A; Baumann S; Egger A; Grize L; Felix B; Kraenzlin M; Henzen C; Meier C. Calcified Tissue International. 2022.

Antidiabetic Treatment, Level of Glycemic Control, and Risk of Fracture in Type 2 Diabetes: a Nested, Case-Control Study.

Charlier S; Vavanikunnel J; Becker C; Jick SS; Meier C; Meier CR. Journal of Clinical Endocrinology and Metabolism. 2021.

Effect of hyponatremia normalization on osteoblast function in patients with SIAD

Potasso L.; Refardt J.; Meier C.; Christ-Crain M.. European journal of endocrinology. 2021.

2020 recommendations for osteoporosis treatment according to fracture risk from the Swiss Association against Osteoporosis (SVGO).

Ferrari S; Lippuner K; Lamy O; Meier C. Swiss medical weekly. 2020.

Fracture risk and management of discontinuation of denosumab therapy: a systematic review and position statement by ECTS.

Tsourdi E; Zillikens MC; Meier C; Body JJ; Gonzalez Rodriguez E; Anastasilakis AD; Abrahamsen B; McCloskey E; Hofbauer LC; Guañabens N; Obermayer-Pietsch B; Ralston SH; Eastell R; Pepe J; Palermo A; Langdahl B. Journal of Clinical Endocrinology and Metabolism. 2020.

High impact physical activity and bone health of lower extremities in childhood cancer survivors: A cross-sectional study of SURfit.

Zürcher SJ; Jung R; Monnerat S; Schindera C; Eser P; Meier C; Rueegg CS; von der Weid NX; Kriemler S. International Journal of Cancer. 2020.

Osteoporosis in Premenopausal Women: A Clinical Narrative Review by the ECTS and the IOF

Pepe J.; Body J.-J.; Hadji P.; McCloskey E.; Meier C.; Obermayer-Pietsch B.; Palermo A.; Tsourdi E.; Zillikens M.C.; Langdahl B.; Ferrari S.. Journal of Clinical Endocrinology and Metabolism. 2020.

Zoledronic acid is more efficient than ibandronic acid in the treatment of symptomatic bone marrow lesions of the knee.

Müller F; Appelt KA; Meier C; Suhm N. Knee Surgery, Sports Traumatology, Arthroscopy. 2020.

Association Between Glycemic Control and Risk of Fracture in Diabetic Patients: A Nested Case-Control Study.

Vavanikunnel J; Charlier S; Becker C; Schneider C; Jick SS; Meier CR; Meier C. Journal of Clinical Endocrinology and Metabolism. 2019.

Bone disease following solid organ transplantation: A narrative review and recommendations for management from The European Calcified Tissue Society.

Anastasilakis AD; Tsourdi E; Makras P; Polyzos SA; Meier C; McCloskey EV; Pepe J; Zillikens MC. Bone. 2019.

Comparison of Five TSH-Receptor Antibody Assays in Graves' disease: results from an observational pilot study.

Struja T; Jutzi R; Imahorn N; Kaeslin M; Boesiger F; Kutz A; Mundwiler E; Huber A; Kraenzlin M; Mueller B; Meier C; Bernasconi L; Schuetz P. BMC Endocrine Disorders. 2019.

Diagnosis, prevention, and treatment of bone fragility in people living with HIV: a position statement from the Swiss Association against Osteoporosis.

Biver E; Calmy A; Aubry-Rozier B; Birkhäuser M; Bischoff-Ferrari HA; Ferrari S; Frey D; Kressig RW; Lamy O; Lippuner K; Suhm N; Meier C. Osteoporosis International. 2019.

Fibroblast growth factor 21 predicts outcome in community-acquired pneumonia: secondary analysis of two randomised controlled trials.

Ebrahimi F; Wolffenbuttel C; Blum CA; Baumgartner C; Mueller B; Schuetz P; Meier C; Kraenzlin M; Christ-Crain M; Betz MJ. European Respiratory Journal. 2019.

Metabolomics and Their Ability to Distinguish Thyroid Disorders: A Retrospective Pilot Study.

Struja T; Eckart A; Kutz A; Neyer P; Kraenzlin M; Mueller B; Meier C; Bernasconi L; Schuetz P. Hormone and Metabolic Research. 2019.

Reply to "Antiretroviral therapy options in people living with HIV at risk of or with osteoporosis. Comment on: Diagnosis, prevention, and treatment of bone fragility in people living with HIV: a position statement from the Swiss Association against Osteoporosis" by S. Noe, H. Jaeger, E. Wolf.

Biver E; Calmy A; Meier C. . 2019.

Hypercalcemic crisis in third trimenon: evaluating the optimal treatment strategy.

Refardt J; Farina P; Hoesli I; Meier C. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology. 2018.

Metabolomics for Prediction of Relapse in Graves' Disease: Observational Pilot Study.

Struja T; Eckart A; Kutz A; Huber A; Neyer P; Kraenzlin M; Mueller B; Meier C; Bernasconi L; Schuetz P. Frontiers in endocrinology. 2018.

A partially supervised physical activity program for adult and adolescent survivors of childhood cancer (SURfit): study design of a randomized controlled trial [NCT02730767].

Rueegg CS; Kriemler S; Zuercher SJ; Schindera C; Renner A; Hebestreit H; Meier C; Eser P; von der Weid NX. BMC Cancer. 2017.

Bone mineral density and its determinants in men with opioid dependence.

Gotthardt F; Huber C; Thierfelder C; Grize L; Kraenzlin M; Scheidegger C; Meier C. JOURNAL OF BONE AND MINERAL METABOLISM. 2017.

External validation of the GREAT score to predict relapse risk in Graves' disease: results from a multicenter, retrospective study with 741 patients.

Struja T; Kaeslin M; Boesiger F; Jutzi R; Imahorn N; Kutz A; Bernasconi L; Mundwiler E; Mueller B; Christ-Crain M; Meienberg F; Ebrahimi F; Henzen C; Fischli S; Kraenzlin M; Meier C; Schuetz P. European journal of endocrinology. 2017.

Is Graves' disease a primary immunodeficiency? New immunological perspectives on an endocrine disease.

Struja T; Kutz A; Fischli S; Meier C; Mueller B; Recher M; Schuetz P. BMC Medicine. 2017.

Osteoporosis drug treatment: duration and management after discontinuation. A position statement from the SVGO/ASCO.

Meier C; Uebelhart B; Aubry-Rozier B; Birkhäuser M; Bischoff-Ferrari HA; Frey D; Kressig RW; Lamy O; Lippuner K; Stute P; Suhm N; Ferrari S. Swiss medical weekly. 2017.

Personalised immunomodulating treatments for Graves' disease: fact or fiction?

Struja TM; Kutz A; Fischli S; Meier C; Müller B; Schütz P. Swiss medical weekly. 2017.

[FLS - three letters alter secondary fracture prevention].

Suhm N; Meier C; Kraenzlin M; Kungler E; Savic B; Mueller S; Jakob M; Rikli D. Unfallchirurg. 2016.

Achilles or biceps tendon rupture in women and men with type 2 diabetes: A population-based case-control study.

Spoendlin J; Meier C; Jick SS; Meier CR. JOURNAL OF DIABETES AND ITS COMPLICATIONS. 2016.

Capture the fracture by SMS

Theiler, R.; Freystaetter, G.; Platz, A.; Meier, C.; Mellinghoff, H. -U.. Osteologie. 2016.

Clinical presentation and management of patients with primary hyperparathyroidism of the Swiss Primary Hyperparathyroidism Cohort: A focus on neuro-behavioral and cognitive symptoms

Trombetti A.; Christ E.R.; Henzen C.; Gold G.; Brandle M.; Herrmann F.R.; Torriani C.; Triponez F.; Kraenzlin M.; Rizzoli R.; Meier C.. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION. 2016.

Effects of diabetes drugs on the skeleton.

Meier C; Schwartz AV; Egger A; Lecka-Czernik B. Bone. 2016.

Effects of diabetes drugs on the skeleton.

Meier C; Schwartz AV; Egger A; Lecka-Czernik B. Bone. 2016.

Effects of Incretin-Based Therapies and SGLT2 Inhibitors on Skeletal Health.

Egger A; Kraenzlin ME; Meier C. Current Osteoporosis Reports. 2016.

Effects of Incretin-Based Therapies and SGLT2 Inhibitors on Skeletal Health.

Egger A; Kraenzlin ME; Meier C. Current Osteoporosis Reports. 2016.

New Use of Statins and the Risk of Achilles or Biceps Tendon Rupture: A Propensity-Score Matched Cohort Study

Spoendlin, Julia; Layton, J. Bradley; Mundkur, Mallika; Meier, Christian; Jick, Susan S.; Meier, Christoph R.. Pharmacoepidemiology and Drug Safety. 2016.

Osteoporosis and type 2 diabetes

Egger, A.; Kraenzlin, M.; Meier, C.. Diabetologe. 2016.

Surgical Timing and the Menstrual Cycle Affect Wound Healing in Young Breast Reduction Patients.

Oranges CM; Meier C; Schaefer DJ. Plastic and reconstructive surgery. 2016.

The Risk of Achilles or Biceps Tendon Rupture in New Statin Users: A Propensity Score-Matched Sequential Cohort Study.

Spoendlin J; Layton JB; Mundkur M; Meier C; Jick SS; Meier CR. Drug safety. 2016.

Benefits and place of calcimimetics in the management of primary hyperparathyroidism.

Meier C. Annales d'endocrinologie. 2015.

Oral and inhaled glucocorticoid use and risk of Achilles or biceps tendon rupture: a population-based case-control study.

Spoendlin J; Meier C; Jick SS; Meier CR. Annals of Medicine. 2015.

[In Process Citation]

De Geyter,Christian; Birkhäuser,Martin. Therapeutische Umschau. 2014.

Bisphosphonate induced hypocalcaemia - report of six cases and review of the literature.

Kreutle V; Blum C; Meier C; Past M; Müller B; Schütz P; Borm K. Swiss medical weekly. 2014.

Effect of ibandronate on spontaneous osteonecrosis of the knee: a randomized, double-blind, placebo-controlled trial.

Meier C; Kraenzlin C; Friederich NF; Wischer T; Grize L; Meier CR; Kraenzlin ME. Osteoporosis International. 2014.

Gynaecologists' awareness of bone healthcare in Switzerland.

Stute P; Birkhäuser M; von Wolff M; Meier C. Swiss medical weekly. 2014.

Testosterone replacement therapy in the aging male - Risks and benefits Hormonersatzbehandlung in der andropause - Nutzen und risiken

Nigro N.; Christ-Crain M.; Meier C.. Therapeutische Umschau. 2014.

The role of teriparatide in sequential and combination therapy of osteoporosis

Meier, Christian; Lamy, Olivier; Krieg, Marc-Antoine; Mellinghoff, Hans-Ulrich; Felder, Markus; Ferrari, Serge; Rizzoli, Rene. Swiss Medical Weekly. 2014.

[Laboratory investigation of endocrine function - interpretation of results and pitfalls].

Henzen C; Kraenzlin M; Meier C. Therapeutische Umschau. 2013.

Intravenous bisphosphonates for postmenopausal osteoporosis: safety profiles of zoledronic acid and ibandronate in clinical practice.

Sieber P; Lardelli P; Kraenzlin CA; Kraenzlin ME; Meier C. Clinical drug investigation. 2013.

[Osteoporosis: evaluation, diagnosis and monitoring].

Meier C; Kraenzlin ME. Therapeutische Umschau. 2012.

Use of antidiabetic agents and the risk of pancreatic cancer: a case-control analysis.

Bodmer M; Becker C; Meier C; Jick SS; Meier CR. American Journal of Gastroenterology. 2012.

Use of metformin is not associated with a decreased risk of colorectal cancer: a case-control analysis.

Bodmer M; Becker C; Meier C; Jick SS; Meier CR. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2012.

[Primary hyperparathyroidism].

Suter-Widmer I; Kraenzlin ME; Meier C. Therapeutische Umschau. 2011.

Antiepileptics and bone health.

Meier C; Kraenzlin ME. Therapeutic Advances in Musculoskeletal Disease. 2011.

Calcium supplementation, osteoporosis and cardiovascular disease.

Meier C; Kränzlin ME. Swiss medical weekly. 2011.

Parathyroid hormone analogues in the treatment of osteoporosis.

Kraenzlin ME; Meier C. Nature reviews. Endocrinology. 2011.

Use of metformin and the risk of ovarian cancer: a case-control analysis.

Bodmer M; Becker C; Meier C; Jick SS; Meier CR. Gynecologic oncology. 2011.

Impact of bisphosphonate wash-out prior to teriparatide therapy in clinical practice.

Keel C; Kraenzlin ME; Kraenzlin CA; Müller B; Meier C. JOURNAL OF BONE AND MINERAL METABOLISM. 2010.

Long-term metformin use is associated with decreased risk of breast cancer.

Bodmer M; Meier C; Krähenbühl S; Jick SS; Meier CR. Diabetes Care. 2010.

Possible beneficial effect of bisphosphonates in osteonecrosis of the knee.

Kraenzlin ME; Graf C; Meier C; Kraenzlin C; Friedrich NF. Knee Surgery, Sports Traumatology, Arthroscopy. 2010.

Procalcitonin levels predict clinical course and progression-free survival in patients with medullary thyroid cancer.

Walter MA; Meier C; Radimerski T; Iten F; Kränzlin M; Müller-Brand J; de Groot JW; Kema IP; Links TP; Müller B. Cancer. 2010.

Proton pump inhibitors and fracture risk: true effect or residual confounding?

Bodmer M; Meier C; Kraenzlin ME; Meier CR. Drug safety. 2010.

Use of depot medroxyprogesterone acetate and fracture risk.

Meier C; Brauchli YB; Jick SS; Kraenzlin ME; Meier CR. Journal of Clinical Endocrinology and Metabolism. 2010.

[Osteoporosis: diagnostic assessment].

Meier C. Praxis. 2009.

[Thiazolidinediones and skeletal health].

Meier C; Bodmer M; Meier CR; Kraenzlin ME. Revue Medicale Suisse. 2009.

Age and gender distribution of primary hyperparathyroidism and incidence of surgical treatment in a European country with a particularly high life expectancy.

Richert L; Trombetti A; Herrmann FR; Triponez F; Meier C; Robert JH; Rizzoli R. Swiss Medical Weekly. 2009.

Pattern of thyroid function during early pregnancy in women diagnosed with subclinical hypothyroidism and treated with l-thyroxine is similar to that in euthyroid controls.

De Geyter C; Steimann S; Müller B; Kränzlin ME; Meier C. Thyroid. 2009.

Risk of fractures with glitazones: a critical review of the evidence to date.

Bodmer M; Meier C; Kraenzlin ME; Meier CR. Drug safety. 2009.

Use of bone turnover markers in the real world: are we there yet?

Meier C; Seibel MJ; Kraenzlin ME. Journal of Bone and Mineral Research. 2009.

Aromatasehemmer und Osteoporose

Meier,C; Kränzlin,ME. . 2008.

Automated HPLC assay for urinary collagen cross-links: effect of age, menopause, and metabolic bone diseases.

Kraenzlin ME; Kraenzlin CA; Meier C; Giunta C; Steinmann B. Clinical chemistry. 2008.

Endogenous sex hormones and incident fracture risk in older men: the Dubbo Osteoporosis Epidemiology Study.

Meier C; Nguyen TV; Handelsman DJ; Schindler C; Kushnir MM; Rockwood AL; Meikle AW; Center JR; Eisman JA; Seibel MJ. Archives of Internal Medicine. 2008.

Metformin, sulfonylureas, or other antidiabetes drugs and the risk of lactic acidosis or hypoglycemia: a nested case-control analysis.

Bodmer M; Meier C; Krähenbühl S; Jick SS; Meier CR. Diabetes Care. 2008.

Prävention der Osteoporose

Kränzlin,ME; Meier,C. . 2008.

Use of thiazolidinediones and fracture risk.

Meier C; Kraenzlin ME; Bodmer M; Jick SS; Jick H; Meier CR. Archives of Internal Medicine. 2008.

Age-related changes in serum testosterone and sex hormone binding globulin in Australian men: longitudinal analyses of two geographically separate regional cohorts.

Liu PY; Beilin J; Meier C; Nguyen TV; Center JR; Leedman PJ; Seibel MJ; Eisman JA; Handelsman DJ. Journal of Clinical Endocrinology and Metabolism. 2007.

Bone turnover in elderly men: relationships to change in bone mineral density.

Nguyen TV; Meier C; Center JR; Eisman JA; Seibel MJ. BMC Musculoskeletal Disorders. 2007.

Does continued alendronate therapy improve bone mineral density and reduce fracture risk in postmenopausal women?

Kraenzlin ME; Meier C. NAT CLIN PRACT ENDOC (PRINT-AUSGABE). 2007.

Serum cathepsin K concentrations reflect osteoclastic activity in women with postmenopausal osteoporosis and patients with Paget's disease.

Meier C; Meinhardt U; Greenfield JR; De Winter J; Nguyen TV; Dunstan CR; Seibel MJ. Clinical Laboratory. 2006.

Use of recombinant human thyroid-stimulating hormone in the management of well-differentiated thyroid cancer.

Kraenzlin ME; Meier C. Expert opinion on biological therapy. 2006.

Bone resorption and osteoporotic fractures in elderly men: the dubbo osteoporosis epidemiology study.

Meier C; Nguyen TV; Center JR; Seibel MJ; Eisman JA. Journal of Bone and Mineral Research. 2005.

Diagnose und Therapie der postmenopausalen Osteoporose

Meier,C; Kraenzlin,M.E.. . 2005.

Endocrine regulation of bone turnover in men.

Meier C; Liu PY; Handelsman DJ; Seibel MJ. Clinical Endocrinology. 2005.

Pro-A-type and N-terminal pro-B-type natriuretic peptides in different thyroid function states.

Christ-Crain M; Morgenthaler NG; Meier C; Müller C; Nussbaumer C; Bergmann A; Staub JJ; Müller B. Swiss Medical Weekly. 2005.

Serum estradiol after single dose hCG administration correlates with Leydig cell reserve in hypogonadal men: reassessment of the hCG stimulation test.

Meier C; Christ-Crain M; Christoffel-Courtin C; Staub JJ; Müller B. Clinical Laboratory. 2005.

Ubiquitin-associated domain mutations of SQSTM1 in Paget's disease of bone: evidence for a founder effect in patients of British descent.

Lucas GJ; Hocking LJ; Daroszewska A; Cundy T; Nicholson GC; Walsh JP; Fraser WD; Meier C; Hooper MJ; Ralston SH. Journal of Bone and Mineral Research. 2005.

Value of gonadotropin-releasing hormone testing in the differential diagnosis of androgen deficiency in elderly men.

Christ-Crain M; Meier C; Huber PR; Zimmerli L; Mueller B. Journal of Clinical Endocrinology and Metabolism. 2005.

Comparison of different methods for the measurement of serum testosterone in the aging male.

Christ-Crain M; Meier C; Huber P; Zimmerli L; Trummler M; Müller B. Swiss Medical Weekly. 2004.

Effect of L-Thyroxine Replacement Therapy on Skeletal and Cardiac Function in Subclinical Hypothyroidism

Christ-Crain,M; Meier,C; Huber,P.R.; Keller,U; Staub,J.J.; Müller,B. . 2004.

Established therapeutic options in postmenopausal osteoporosis

Meier,C; Kränzlin,ME. Gynäkologie Praxis. 2004.

Is there a clinical relevance of partial androgen deficiency of the aging male?

Christ-Crain M; Mueller B; Gasser TC; Kraenzlin M; Trummler M; Huber P; Meier C. Journal of Urology. 2004.

Recombinant human chorionic gonadotropin but not dihydrotestosterone alone stimulates osteoblastic collagen synthesis in older men with partial age-related androgen deficiency.

Meier C; Liu PY; Ly LP; de Winter-Modzelewski J; Jimenez M; Handelsman DJ; Seibel MJ. Journal of Clinical Endocrinology and Metabolism. 2004.

Restoration of euthyroidism accelerates bone turnover in patients with subclinical hypothyroidism: a randomized controlled trial.

Meier C; Beat M; Guglielmetti M; Christ-Crain M; Staub JJ; Kraenzlin M. Osteoporosis International. 2004.

Seasonal variation of bone turnover?

Seibel MJ; Meier C; Woitge H; Witte K; Lemmer B. Journal of Bone and Mineral Research. 2004.

Supplementation with oral vitamin D3 and calcium during winter prevents seasonal bone loss: a randomized controlled open-label prospective trial.

Meier C; Woitge HW; Witte K; Lemmer B; Seibel MJ. Journal of Bone and Mineral Research. 2004.

[A 45-year-old woman patient with thigh pain].

Bendik CF; Meier Ch. Praxis. 2003.

[Left-sided chest pain].

Mosimann T; Meier C. Praxis. 2003.

Effect of restoration of euthyroidism on peripheral blood cells and erythropoietin in women with subclinical hypothyroidism.

Christ-Crain M; Meier C; Huber P; Zulewski H; Staub JJ; Müller B. Hormones-International Journal of Endocrinology and Metabolism. 2003.

Elevated C-reactive protein and homocysteine values: cardiovascular risk factors in hypothyroidism? A cross-sectional and a double-blind, placebo-controlled trial.

Christ-Crain M; Meier C; Guglielmetti M; Huber PR; Riesen W; Staub JJ; Müller B. Atherosclerosis. 2003.

Prolactin dysregulation in women with subclinical hypothyroidism: effect of levothyroxine replacement therapy.

Meier C; Christ-Crain M; Guglielmetti M; Huber P; Staub JJ; Müller B. Thyroid. 2003.

Serum thyroid stimulating hormone in assessment of severity of tissue hypothyroidism in patients with overt primary thyroid failure: cross sectional survey.

Meier C; Trittibach P; Guglielmetti M; Staub JJ; Müller B. BMJ (Clinical research ed.). 2003.

[Mental changes in hypo- and hyperthyroidism].

Meier C; Christ-Crain M; Keller U; Staub JJ. Deutsche Medizinische Wochenschrift. 2002.

Basal TSH levels compared with TRH-stimulated TSH levels to diagnose different degrees of TSH suppression: diagnostic and therapeutic impact of assay performance.

Christ-Crain M; Meier C; Roth CB; Huber P; Staub JJ; Müller B. European Journal of Clinical Investigation. 2002.

Combined stimulation of adrenocorticotropin and compound-S by single dose metyrapone test as an outpatient procedure to assess hypothalamic-pituitary-adrenal function.

Berneis K; Staub JJ; Gessler A; Meier C; Girard J; Müller B. Journal of Clinical Endocrinology and Metabolism. 2002.

Prospective study of the spontaneous course of subclinical hypothyroidism: prognostic value of thyrotropin, thyroid reserve, and thyroid antibodies.

Huber G; Staub JJ; Meier C; Mitrache C; Guglielmetti M; Huber P; Braverman LE. Journal of Clinical Endocrinology and Metabolism. 2002.

[Thyrotoxic crisis].

Zimmermann I; Meier C. Praxis. 2001.

TSH-controlled L-thyroxine therapy reduces cholesterol levels and clinical symptoms in subclinical hypothyroidism: a double blind, placebo-controlled trial (Basel Thyroid Study).

Meier C; Staub JJ; Roth CB; Guglielmetti M; Kunz M; Miserez AR; Drewe J; Huber P; Herzog R; Müller B. Journal of Clinical Endocrinology and Metabolism. 2001.

[Amiodarone-induced thyrotoxicosis].

Kaufmann C; Cron TA; Meier C; Staub JJ; Oberholzer M; Osswald S. Swiss medical weekly. 2000.

[Long-term study of subclinical hypothyroidism: spontaneous course and predictors of manifest hypothyroidism].

Huber G; Mitrache C; Meier C; Guglielmetti M; Huber P; Staub JJ. Swiss medical weekly. 1998.

[Ultrasensitive TSH screening for detection of thyroid gland dysfunctions in women of a medical ambulatory care patient group].

Meier C; Staub JJ; Roth CB; Kunz M; Guglielmetti M; Martina B; Huber P. Swiss medical weekly. 1998.

[Influence of beta-blocking agents on experimental atherosclerosis of cocks (author's transl)].

Reinis Z; Lojda Z; Heyrovský A; Horáková D; Reisenauer R. Casopis Lekaru Ceskych. 1975.

Cytotoxic interaction between gorgonian explants: mode of action.

Theodor JL; Senelar R. Cellular immunology. 1975.

Mercury inhibition of avian fatty acid synthetase complex.

Donaldson WE. CHEMICO-BIOLOGICAL INTERACTIONS. 1975.

Some characteristics of two azoreductase systems in rat liver. Relevance to the activity of 2-[4'-di(2"-bromopropyl)-aminophenylazo]benzoic acid (CB10-252), a compound possessing latent cytotoxic activity.

Autrup H; Warwick GP. CHEMICO-BIOLOGICAL INTERACTIONS. 1975.

The effects of the continuous administration of N,N-dimethyl-4-phenylazoaniline (DAB) on the activities and the inducibilities of some drug-metabolizing enzymes in rat liver.

Autrup H; Thurlow BJ; Warwick GP. CHEMICO-BIOLOGICAL INTERACTIONS. 1975.

Extrauterine abdominal pregnancy.

Meier,C; Kraenzlin,M.E.. Acta Medica. 1961.